Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Degawa, M.
Right arrow Articles by Hashimoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degawa, M.
Right arrow Articles by Hashimoto, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

Expression and induction of cytochrome P450 isozymes in hyperplastic nodules of rat liver

Masakuni Degawa, Shin-ichi Miura and Yoshiyuki Hashimoto

Department of Hygienic Chemistry, Pharmaceutical Institute, Tohoku University Aobayama, Sendai 980, Japan

The change of cytochrome P450 (P450) isozymes in a early stage of hepatocarcinogenesis in male F344 rats has been studied. Liver microsomes were prepared from normal rats (group 1), rats treated with diethylnitrosamine (DEN) alone, which developed no hyperplastic nodules (group 2), and rats treated with DEN plus 2-acetylaminofluorene, which developed many hyperplastic nodules (group 3). The amount and activity of P450IA1 and P450IA2 expressed in the liver were analyzed by several immunological methods using monoclonal antibodies against the P450 isozymes and a mutagenicity test. In the group 2 and 3 rats, the total amount of P450 and the amount of P450IA2 were much smaller than those in the group 1 rats, and P450IA1 was detected only from the group 3 rats. As observed by immunohistochemistry, P450IA1 was prominent in hyperplastic nodules developed in the group 3 rats, and the distribution of P45OIA1+ cells in individual nodules was heterogeneous. When the rats were treated with a P450 inducer, 3-methoxy-4-aminoazobenzene or 3-methylcholanthrene, both P450IA1 and P450IA2 were induced in all groups of rats; however, the induction rates of the P450 isozymes, especially that of P450IA2, in the group 3 rats were smaller than those in the group 1 and 2 rats. The present work demonstrated that P450IA1, which is responsible mainly for detoxication of aromatic amine carcinogens, increased in level along with the development of hyperplastic nodules, whereas P450IA2, which is responsible for mutagenic or carcinogenic activation of these carcinogens, decreased in its amount and inducibility.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J BiochemHome page
M. Degawa, M. Namiki, N. Yoshimoto, M. Makino, M. Iwamoto, K. Nemoto, and Y. Hashimoto
Constitutive Expression of Cytochrome P450 Genes in Newly Established Rat Hepatic Cell Lines
J. Biochem., June 1, 2003; 133(6): 825 - 831.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Fukuda, M. Ebara, M. Okuyama, N. Sugiura, M. Yoshikawa, H. Saisho, R. Shimizu, N. Motoji, A. Shigematsu, and T. Watayo
Increased metabolizing activities of the tricarboxylic acid cycle and decreased drug metabolism in hepatocellular carcinoma
Carcinogenesis, December 1, 2002; 23(12): 2019 - 2023.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Kasahara, M. Hashiba, T. Harada, and M. Degawa
Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats
Carcinogenesis, March 1, 2002; 23(3): 491 - 498.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.